Clinical Trials Logo

Cognition clinical trials

View clinical trials related to Cognition.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06384586 Completed - Cognition Clinical Trials

Investigation of Dietary Supplement Liquid Shot Products on Mental Energy, Cognition (Acuity),and Mood

Start date: November 17, 2022
Phase: N/A
Study type: Interventional

This is a single center, randomized, double blind, placebo-controlled, crossover study to determine the acute effect of a developmental dietary supplement liquid shot product on cognitive task performance and perceived effect measures related to mood and mental energy. The study will be conducted in healthy participants.

NCT ID: NCT06370286 Completed - Exercise Clinical Trials

The Effect of Acute Concurrent Exercise on Inhibitory Control: An Event-related Potential Study

Start date: February 15, 2021
Phase: N/A
Study type: Interventional

The present study aimed to determine the effects of acute concurrent exercise on inhibitory control via behavioral and event-related potential approaches and to examine its potential mediational role on lactate among younger adults. The main questions it aims to answer are: (1) Does acute concurrent exercise improve inhibitory control via behavioral and event-related potential approaches? (2) Does lactate play a potential mediational role in the effect of acute concurrent exercise on inhibitory control?

NCT ID: NCT06019858 Completed - Fatigue Clinical Trials

A Clinical Trial to Assess the Effects of a Vitamin Shot on Energy Levels

Start date: June 21, 2023
Phase: N/A
Study type: Interventional

This is a virtual, single-arm clinical trial that will last 30 days. Participants will drink 1 bottle of the Vitamin Energy® shot daily and complete questionnaires at baseline, Day 7, Day 14, and Day 30. Participants' energy, mood, and cognitive function will be evaluated at baseline and at each check-in. Bodyweight will also be assessed at baseline and Day 30. Likert scale responses will be examined from baseline to each check-in. Participant responses on product feedback will be presented as % scores.

NCT ID: NCT05998096 Completed - Cognition Clinical Trials

A Randomized Study to Examine the Ability of a Caffeine-Based Energy Drink to Impact Energy Expenditure, Fat Oxidation, Reaction Time, and Other Perceptual Indicators

ASH
Start date: September 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the changes in energy expenditure, fat oxidation, reaction time, and perceptual indicators of energy and focus after acute ingestion of a caffeine-based energy drink. Approximately 60 healthy adults aged 18-50 will be recruited for a randomized, double-blind, placebo-controlled study. They will undergo baseline measurements for energy expenditure, fat and carbohydrate oxidation, reaction time, cognition, and perceptual indicators of energy, focus, and concentration. After 28 days, these measurements will be taken again, comparing the effects of a caffeine-based energy drink versus a placebo.

NCT ID: NCT05911490 Completed - Cognition Clinical Trials

Effects of Breaking Sitting on Human Behaviour and Metabolic Health

Start date: December 20, 2019
Phase: N/A
Study type: Interventional

This study primarily aimed to investigate effects of breaking up prolonged sitting with intermittent brisk walking in healthy young individuals on (1) post-trial human behaviours including energy intake and physical activity under free-living conditions and (2) cognitive performance in a simulated workplace environment.

NCT ID: NCT05625776 Completed - Pain, Acute Clinical Trials

Effects of Acute Pain on Cognitive Performance in Young Adults

Start date: March 22, 2023
Phase: N/A
Study type: Interventional

The effects of pain on cognitive performance have not been thoroughly investigated. Broadly, the purpose of this research is to investigate the effects of acute pain on performance of a variety of cognitive performance measures. The investigators hypothesize that acute pain impairs cognitive performance, particularly cognitive measures of working memory, attention, and processing speed.

NCT ID: NCT05462977 Completed - Depression Clinical Trials

Rhythmically Entrained Exercise in Community-Dwelling Older Adults

REECO
Start date: May 1, 2022
Phase: N/A
Study type: Interventional

Researchers at the University of North Carolina at Greensboro conduct a single-arm intervention trial to investigate the efficacy of a music-based group exercise program for community-dwelling older adults. Up to forty participants will be recruited to participate in a music-based light-to-moderate intensity group exercise program for 20 weeks (30 - 40 min/day, up to 6 days/week), which is designed for older adults with or without functional limitations to exercise with chairs for the improvement of aerobic capacity, upper and lower body strength, and balance control at a gradually increasing pace. During the exercise sessions, participants will be trained to move in time with music playlists in synchronous tempos. Primary outcomes are cognitive performance, mobility, and health-related quality of life measured before and after the intervention. Secondary outcomes are adherence to the exercise program as a potential mediator of the treatment.

NCT ID: NCT05411185 Completed - Cognition Clinical Trials

The Study on Effects of Acute Exposure to High Altitude Hypoxia on Cognitive Function in Lowlanders

Start date: January 1, 2022
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to investigate the impact of rapid elevation to 3,800 meters on the cognitive function of low-altitude residents through a plateau field and plain control study, and explore the objective indicators related to the impaired cognitive function.

NCT ID: NCT05352568 Completed - Schizophrenia Clinical Trials

Is Cognitive Training an Option?

Start date: May 2, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the feasibility of implementing cognitive training with 40 patients living with schizophrenia and schizoaffective disorder. The study aims to explore if cognitive training as an intervention can improve cognition, symptomology, social cognition, and psychosocial function which has been determined through literature to be impacted within this population. The results of this study will help shed light on utilizing additional resources to aid in decreasing relapse and continued hospitalizations.

NCT ID: NCT05341804 Completed - Schizophrenia Clinical Trials

Cognitive and Balance Dual Task Training for People With Schizophrenia

Start date: May 10, 2022
Phase: N/A
Study type: Interventional

After developing and pilot testing the training program, including the CogBals software, a 3-arm, single-blinded, randomized controlled trial is used to recruit 84 participants and then randomly allocated to the cognitive and balance dual task training group (COG&BAL), the balance training group (BAL), and the treatment as usual group. The first two training groups (COG&BAL, BAL) receive training for 60 minutes in a group format, 2 times weekly, for 12 weeks. All participants will be assessed at baseline and posttest. The primary outcome is balance function and secondary outcomes are cognitive functions and the muscular endurance of lower extremities.